Research Article

Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation

Table 5

Procedural adverse clinical outcomes in CAD-TAVI group stratified by the performance of PCI.

CAD groupPCI groupNo PCI group value PCI versus no PCI
N = 372N = 255N = 117

Death, N (%)11 (3)7 (2.8)4 (3.4)0.75

Significant complications, N(%)
Major or life-threatening bleeding14 (3.8)12 (4.7)2 (1.7)0.14
Minor bleeding14 (3.8)10 (4)4 (3.4)0.78
Major vascular complication17 (4.6)13 (5.1)4 (3.4)0.44
Minor vascular complication25 (6.7)15 (5.9)10 (8.4)0.37
Stroke9 (2.4)6 (2.4)3 (2.5)0.93
Acute kidney injury8 (2.2)4 (1.6)4 (3.4)0.27
Pacemaker implantation51 (13.7)33 (13)18 (15.1)0.58

CCU admission, N (%)212 (57)134 (53)78 (65.5)0.22

CAD = coronary artery disease. PCI = percutaneous coronary intervention. CCU = cardiac care unit.